Generation Bio Co. (GBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1246882,
    "name": "Generation Bio Co.",
    "stock_name": "Generation Bio Co.",
    "full_name": "Generation Bio Co.",
    "name_url": "stocks-analysis/generation-bio-co",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.22",
    "chg": 0.17,
    "chgp": "3.37%",
    "dir": 1,
    "prev_price": "5.05",
    "mcapval": "39.27",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US37148K1007",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "55.42 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/generation-bio-co-1246882-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Generation Bio Co. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-generation-bio-co-technically-bullish-or-bearish-3547810",
        "imagepath": "",
        "date": "2025-09-20 20:03:36",
        "description": "As of 2 September 2025, the technical trend for Generation Bio Co. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators supporting this view including a mildly bearish daily moving average and a weekly Dow Theory signal also indicating mild bearishness. The MACD shows a mildly bullish signal on both weekly and monthly time frames, but this is countered by a bearish monthly Bollinger Band and a bearish monthly KST. The RSI is bullish on a monthly basis but shows no signal weekly.\n\nIn terms of performance, Generation Bio has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -43.58% compared to the S&P 500's 12.22%, and a one-year return of -76.91% versus the S&P 500's 17.14%...."
      },
      {
        "title": "Is Generation Bio Co. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-generation-bio-co-overvalued-or-undervalued-3544064",
        "imagepath": "",
        "date": "2025-09-20 18:36:37",
        "description": "As of 9 November 2023, the valuation grade for Generation Bio Co. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its significant losses and poor performance metrics. Key ratios include a Price to Book Value of 0.40, an EV to EBIT of 1.63, and an EV to EBITDA of 1.75, which suggest that despite low valuations, the company's financial situation remains precarious.\n\nIn comparison to its peers, Generation Bio Co. has a negative P/E ratio of -0.6048, while Akebia Therapeutics, Inc. shows a much larger negative P/E of -30.5922, and scPharmaceuticals, Inc. has a P/E of -4.3946. This places Generation Bio in a challenging position within the industry. Additionally, the company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -43.58% compared to the index's 12.22%, reinfor..."
      }
    ],
    "total": 7,
    "sid": "1246882",
    "stock_news_url": "https://www.marketsmojo.com/news/generation-bio-co-1246882"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Generation Bio Co. technically bullish or bearish?

2025-09-20 20:03:36

As of 2 September 2025, the technical trend for Generation Bio Co. has changed from sideways to mildly bearish. The current stance is bearish, with key indicators supporting this view including a mildly bearish daily moving average and a weekly Dow Theory signal also indicating mild bearishness. The MACD shows a mildly bullish signal on both weekly and monthly time frames, but this is countered by a bearish monthly Bollinger Band and a bearish monthly KST. The RSI is bullish on a monthly basis but shows no signal weekly. In terms of performance, Generation Bio has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -43.58% compared to the S&P 500's 12.22%, and a one-year return of -76.91% versus the S&P 500's 17.14%....

Is Generation Bio Co. overvalued or undervalued?

2025-09-20 18:36:37

As of 9 November 2023, the valuation grade for Generation Bio Co. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its significant losses and poor performance metrics. Key ratios include a Price to Book Value of 0.40, an EV to EBIT of 1.63, and an EV to EBITDA of 1.75, which suggest that despite low valuations, the company's financial situation remains precarious. In comparison to its peers, Generation Bio Co. has a negative P/E ratio of -0.6048, while Akebia Therapeutics, Inc. shows a much larger negative P/E of -30.5922, and scPharmaceuticals, Inc. has a P/E of -4.3946. This places Generation Bio in a challenging position within the industry. Additionally, the company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -43.58% compared to the index's 12.22%, reinfor...

View All News